Violet™ is a new artificial intelligence-based tool that will help provide clinicians and patients with an informative report assessing the viability of the patient's eggs. This technology is used in elective fertility preservation to assess the chances of each egg before freezing it so that the best egg can be implanted when the patient is ready to use it.
When high sperm DNA fragmentation is observed, it is important to select sperm with lower DNA fragmentation to facilitate embryo development and implantation. The ZyMōt selection device enables the selection of sperm with low DNA fragmentation, and avoids the use of the centrifuge in the sperm preparation process, thereby removing an additional potential source of fragmentation in sensitive samples.
This technique can be recommended in cases of obstructive azoospermia when spermatozoids are present and mature, but are unable to leave the epididymis. An example of when this may be recommended is when the vas deferens are obstructed (e.g. following a vasectomy) or completely absent.
This procedure is an option for people who lack sperm production in the epididymis due to previous surgery, infection or a congenital defect.
Micro-TESE is the best option for people with non-obstructive azoospermia, those with insufficient sperm production or maturation. This microsurgery technique allows the specialist to identify the areas where sperm is produced.
The Alessio sperm DNA fragmentation test uses fluorescent biomarkers to measure the proportion of sperm with fragmented DNA. The quality of the genetic information carried by the sperm is a determining factor in the development of a viable embryo. Sperm DNA fragmentation corresponds to “breaks” in the sperm’s genetic material that cannot be detected by conventional examinations. A high number of breaks reduces the chances that a pregnancy will be carried to term, and could be the cause of certain fertility problems.
adhesioRT is an endometrial receptivity test that complements conventional assisted reproduction techniques. This test allows a personalized embryo transfer by identifying the precise moment when the endometrium is receptive. It is thus possible to synchronize the dialogue between the embryo and the endometrium, and increase the potential for pregnancy. The adhesioRT test is a key complement to conventional assisted reproduction techniques by optimizing the chances of embryo implantation following transfer.
The process of removing small fragments of the inner lining of the uterus by aspiration to rule out chronic endometritis or other pathologies.
This treatment is used to mimic a natural cycle with a pump that secretes LHRH. The LHRH pump treatment mimics your brain’s action and allows you to ovulate more naturally than if you were receiving more intensive hormone treatments.
Traditionally, during an in vitro fertilization (IVF) cycle, the embryos are removed from the incubator once per day for a very limited period of time in order to assess their development. With the Time Lapse technology, the incubator has a camera that takes photos every few minutes from multiple viewpoints in order to build a ‘video’ of the embryo development. This means that, in addition to the embryologist being able to see events that occurred throughout the day and night, the stable environment of the embryo incubator never needs to be disturbed.
PGT allows access to the chromosomal and/or genetic content of the embryo before its transfer into the patient's uterus, thanks to a biopsy of a few cells.
In the case of advanced maternal age, failed implantations or recurrent fetal losses, PGT-A analysis allows prioritizing the transfer of an embryo without chromosomal abnormalities in order to maximize the pregnancy rate and reduce the risk of miscarriage.
In the case of an inherited genetic condition carried by one or both biological parents, the PGT-M analysis allows the identification of unaffected embryos, and can be combined with the PGT-A.
Once the results are available, the selected embryos are thawed and transferred to the patient's uterus.
Inclusion of all gender & sexually diverse people is an important value of clinique ovo. We are continuously striving to create an environment of compassionate belonging where all of the LGBTQ2SIA+ community are supported, valued and respected.
The clinique ovo is located in unceded Indigenous territory. The Kanien’kehá: ka Nation is recognized as the guardian of Montreal / Tiohtiá: ke.
© All rights reserved ovo group 2021